Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-26

Clinical Trial Update: Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating amifostine to reduce treatment-related side effects in patients receiving radiation therapy and cisplatin for advanced head and neck ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amifostine (amifostine)
  • CISPLATIN (cisplatin)

Snippet

Sponsor: University of Tennessee | Conditions: Drug/Agent Toxicity by Tissue/Organ, Head and Neck Cancer | Phase 2 | Status: COMPLETED